Data Analysis Pre-Market: Peregrine Pharmaceuticals, American Airlines, Growlife, and Ariad Pharmaceuticals

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company has received FDA Fast Track designation for one of its products. Get the details at the following link: http://bit.ly/AnalysisPPHM copy and paste to browser may be required

American Airlines Group, Inc. (NASDAQ: AAL) through its subsidiaries, operates in the airline industry. It operates an average of approximately 6,700 flights per day to approximately 339 destinations in 54 countries. AAL has reported December results and discussed consolidating the customer loyalty programs of American airlines and US Airways. Get the detail here, at the link: http://bit.ly/AnalysisAAL copy and paste to browser may be required

Growlife, Inc. (OTCQB: PHOT) is a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software. The company has added a new member to its board of directors. Find out how the new board member may help the growth process at PHOT at this link: http://bit.ly/AnalysisPHOT copy and paste to browser may be required

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) is an oncology company, focused on the discovery, development, and commercialization of medicines for cancer patients. ARIA has issued updated on the progress of its products in development. Get a full report at the link: http://bit.ly/AnalysisARIA copy and paste to browser may be required

Get our stock alerts ahead of the crowd on your mobile device text keyword “Street” to 25827

EDITOR NOTES:

1. Information in this release is fact checked and produced on a best efforts basis and reviewed by Marc Bonacci, Chief Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

2. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

3. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcapstreet.com.

4. For any urgent concerns or inquiries, please contact us at compliance@smallcapstreet.com.

5. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@smallcapstreet.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared by Small Cap Specialists, LLC and authored by Marc Bonacci, Chief Financial Analyst. An outsourced research services provider represented by Marc Bonacci, Chief Financial Analyst, has only reviewed the information provided by Small Cap Specialists, LLC in this article or report. Small Cap Specialists, LLC is not entitled to veto, interfere or alter the articles, documents or report once reviewed by the outsourced research provider represented by Marc Bonacci, Chief Financial Analyst.

NOT FINANCIAL ADVICE

Small Cap Specialists, LLC makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Small Cap Specialists, LLC is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Small Cap Specialists, LLC whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Street, LLC expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Specialists, LLC does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE: SmallCapStreet.com

Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jul 2024 to Aug 2024